Ignite II

gmkb

Home
IGNITE
- ADOPT PGx
- GUARDD-US
IGNITE GDP
Publications
Affiliates
Training Opportunities
News & Events
- News
- Event Calendar

- ADOPT PGx Depression Manuscript Published May 6, 2026
  A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing results from the ADOPT PGx Depression trial. The randomized clinical trial evaluated whether genotype-guided prescribing of selective serotonin reuptake inhibitors (SSRIs) could improve ...
- GUARDD-US APOL1 Genetic Testing Manuscript Published March 6, 2026
  A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...

Search for:

GMKBignite toolbox Implementation Guides

How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A Tutorial

Posted on July 7, 2021October 20, 2021 by Alexis

Cicali EJ, Elchynski AL, Cook KJ, Houder JT, Thomas CD, Smith DM, Elsey A, Johnson JA, Cavallari LH, Wiisanen K. Clin Pharmacol Ther.

2021 Jul 7. doi: 10.1002/cpt.2354. Online ahead of print.

PMID: 34231197

This entry was posted in Publication. Bookmark the permalink.

← Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies

6th SingHealth Duke-NUS Scientific Congress →

Home
IGNITE
- ADOPT PGx
- GUARDD-US
IGNITE GDP
Publications
Affiliates
Training Opportunities
News & Events
- News
- Event Calendar

IGNITE is an NIH-funded network dedicated to supporting the implementation of genomics in healthcare. Contact us to learn more about IGNITE and the work currently being conducted by the network

Contact IGNITE

Privacy Statement

WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.